LTRN earnings: a positive outcome, +14.5%

On March 18, 2024, Lantern Pharma Inc. reached its earnings. The result was a positive outcome, and the stock moved +14.5% in the window around the event. It had already run +110.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.